Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Interim report of the phase III open-label study of Xerecept (corticorelin acetate injection) for treatment of peritumoral brain edema in patients with primary or secondary brain tumors

Mechtler L, Alksne J, Wong E, Arenson E, Recht L, Avgeropolous N, Eisenstat D, Hormigo A, Perry J, Raizer J, Shapiro W, Taylor L, Shulman M, Carr L. Interim report of the phase III open-label study of Xerecept (corticorelin acetate injection) for treatment of peritumoral brain edema in patients with primary or secondary brain tumors. Neuro-Oncology. 2006; 8:446-447.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.